C Berthet, O Raguin, S Chalon, X Tizon, S Serrière, et al.. Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors.
American Association for Cancer Research, Apr 2017, Washington, France.
⟨hal-02386511⟩